- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 2.51M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $68K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $498K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.14M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.56M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.34M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $9.03M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $14.96M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $15.6M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $16.59M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $17.55M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 2.51M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$989K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $11.05M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $13.19M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.13M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $220K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.14M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.98M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$402K |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.78M |